Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04515992 · ClinicalTrials.gov registry record · NA

High Intensity Body-weight Circuit Training in Type 2 Diabetics

A NA study, sponsored by Kennesaw State University.

Completed
Registry status
NA
Development phase
6
Enrollment target

NCT04515992: Completed NA study, sponsored by Kennesaw State University.

NCT04515992 is a NA study that has completed, run by Kennesaw State University. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04515992, a NA study, has completed, sponsored by Kennesaw State University.

COMPLETED
Registry status
NA
Development phase
6 participants
Enrollment target

Study Summary

Exercise has been shown to be effective at improving fitness, as well as markers of glucose tolerance and control, in persons with type 2 diabetes. Recently, several investigations have demonstrated that improvements are realized by patients with high intensity interval exercise which is characterized by periods of vigorous exercise alternated by periods of moderate exercise. Typical interval training sessions require significantly less time to complete than traditional modes of exercise wherein moderate intensity activity is sustained for some time. This may be especially beneficial to those with type 2 diabetes, as lack of time is a frequently cited reason for not engaging in regular exercise. Bodyweight circuit training carries the potential to similarly improve health and metabolic function in persons with type 2 diabetes, and may do so with even a smaller accumulation of exercise because this type of exercise involves a greater percentage of the trainee's muscle mass compared with common forms of interval training (e.g., treadmill or cycle exercise). The purpose of this study is to quantify the effects of 3-4 sessions per week of bodyweight circuit training sustained for 5-10 minutes per session on health-related physical fitness and glucose tolerance/control in people with type 2 diabetes.

Primary Outcome

glycosylated hemoglobin, marker of approximate three month blood glucose environment

Interventions

  • BEHAVIORAL High Intensity Body-weight Circuit Training (HIBC)

Trial Details

FieldValue
Enrollment Target 6 participants
Start Date 2018-03-01
Est. Completion 2018-09-01
Phase NA
Kennesaw State University

8 total trials

What the finished NCT04515992 record still lists

NCT04515992 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).

The record links to 0 conditions, and to 1 intervention - of which High Intensity Body-weight Circuit Training (HIBC) is the first listed.

NCT04515992 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04515992 about?

NCT04515992 is a clinical study titled "High Intensity Body-weight Circuit Training in Type 2 Diabetics". Exercise has been shown to be effective at improving fitness, as well as markers of glucose tolerance and control, in persons with type 2 diabetes. Recently, several investigations have demonstrated that improvements are realized by patients with high intensity interval exercise which is characteriz...

What is the current status of trial NCT04515992?

This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2018-03-01. Estimated completion is 2018-09-01.

What interventions are being tested in trial NCT04515992?

The interventions under investigation include: High Intensity Body-weight Circuit Training (HIBC) (BEHAVIORAL).

Who is sponsoring clinical trial NCT04515992?

This trial is sponsored by Kennesaw State University, which has 8 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04515992's enrollment target sits among peer trials

6 1983rd of 2000 higher than 13 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04515992, the US trial registry maintained by the National Library of Medicine. NCT04515992 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.